Subscribe to Daily Review - your favourite M&A deals update.

Submit Deal

Announced

16 Oct 2019

Synova Capital to invest in Preventx.

Synopsis

Synova Capital agreed to invest in Preventx, provider of online-led sexual health testing and diagnostic services and the only UK company with a fully integrated laboratory model. Financial terms were not disclosed. This is the first investment for Synova's latest vehicle. The GP held a first and final close for Synova IV on its £365m ($463m) hard-cap in June.

Principals

target

PREVENTX

bidder

Synova Capital

Show Details & Financials

Did you work on this deal?

Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.

Market Context

Sort

Seller Team (2)

neil cooper

Owner at PREVENTX

Manager

target

Deal

n/a

Total Value

tim alston

Co-Founder at PREVENTX

Manager

target

Deal

n/a

Total Value

Bidder Team (5)

philip shapiro

Managing Partner at SYNOVA CAPITAL

Investor

bidder

Deals

n/a

Total Value

alisdair livingstone

Partner at Osborne Clarke

Lawyer

bidder

Deals

£ 40 M

Total Value

bethany shingfield

Associate at Osborne Clarke

Lawyer

bidder

Deals

£ 287 M

Total Value

james taylor

‎Associate Director at Osborne Clarke

Lawyer

bidder

Deals

£ 540 M

Total Value

chris yeo

Associate Director at Osborne Clarke

Lawyer

bidder

Deals

n/a

Total Value

Explore dealmakers beyond your search with a free MergerLinks account.

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy